tirzepatide and liver function Can a patient with mildly deranged Tests (LFTs) type 2 diabetes start the Moujaro (tirzepatide) injection? Aesthetic & Diagnostic center in

Bottom line: MeAgain is the daily GLP-1 tracker and companion

Quick M, Shi L

Managing weight and glycaemic control in patients with both Hashimoto's thyroiditis and type 2 diabetes presents unique challenges, as hypothyroidism itself contributes to weight gain, insulin resistance, and metabolic dysfunction

10.3390/ijms23073591 133 PizziC.ManzoliL.ManciniS.BedettiG.FontanaF.CostaG

Some reasonable criteria might be regaining more than 50% of lost weight, weight regain causing return of comorbidities (diabetes, sleep apnea, etc.), or inability to maintain behaviors without medication support despite best efforts

This information should be interpreted with a qualified healthcare provider alongside your complete medical history, including your cholecystectomy date, post-operative GI symptoms, and current weight management goals